Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  National Research Corporation    NRC

NATIONAL RESEARCH CORPORATION

(NRC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/30/2020 12/01/2020 12/02/2020 12/03/2020 12/04/2020 Date
51.31(c) 50.59(c) 48.5(c) 49.19(c) 50(c) Last
35 777 38 032 35 501 36 489 45 514 Volume
-3.88% -1.40% -4.13% +1.42% +1.65% Change
More quotes
Financials (USD)
Sales 2018 120 M - -
Net income 2018 30,0 M - -
Net Debt 2018 25,7 M - -
P/E ratio 2018 34,5x
Yield 2018 1,65%
Sales 2019 128 M - -
Net income 2019 32,4 M - -
Net Debt 2019 23,1 M - -
P/E ratio 2019 52,3x
Yield 2019 1,18%
Capitalization 1 263 M 1 263 M -
EV / Sales 2018 8,08x
EV / Sales 2019 13,0x
Nbr of Employees 472
Free-Float 43,9%
More Financials
Company
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect. The Company's portfolio of subscription-based solutions provides information and... 
More about the company
All news about NATIONAL RESEARCH CORPORATION
12/02NATIONAL RESEARCH : Expired Nigeria Satellites to Be Replaced Soon
AQ
11/13COVID-19 vaccine projects backed by the Canadian government
RE
11/06NATIONAL RESEARCH : Management's Discussion and Analysis of Financial Condition ..
AQ
11/05NATIONAL RESEARCH : NRC Health Awards Annual Scholarship to UNL Students
AQ
11/05NRC Health Awards Annual Scholarship to UNL Students
GL
11/04NATIONAL RESEARCH : Q3 2020 Results Press Release
PU
11/03NATIONAL RESEARCH CORP : Results of Operations and Financial Condition, Change i..
AQ
11/03NATIONAL RESEARCH : 3Q Earnings Snapshot
AQ
11/03NATIONAL RESEARCH CORPORATION : Announces Third Quarter and Year-to-Date 2020 Re..
AQ
11/03National Research Corporation Announces Third Quarter and Year-to-Date 2020 R..
GL
09/21VBI VACCINES : signs agreement with Canada to develop COVID-19 vaccine by 2022
RE
09/04Brazil's Tecpar to trial Russian COVID-19 vaccine in early 2021
RE
08/31Canada wants to be at 'front of line' for coronavirus vaccines, signs deals w..
RE
08/27CANSINO BIOLOGICS : Canada says tensions did not 'necessarily' end COVID-19 vacc..
RE
08/26Chinese vaccine maker's coronavirus program with Canada ends
RE
More news
News in other languages on NATIONAL RESEARCH CORPORATION
2019Les valeurs à suivre aujourd'hui à la Bourse de Paris Lundi 2 décembre 2019
2019CARMAT : feu vert à la reprise de l'étude pivot au Kazakhstan
2019CARMAT : reprise de l'étude PIVOT au Kazakhstan
2019CARMAT : A suivre aujourd'hui
2019CARMAT : peut reprendre son étude Pivot République tchèque
More news
Chart NATIONAL RESEARCH CORPORATION
Duration : Period :
National Research Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NATIONAL RESEARCH CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers
NameTitle
Michael D. Hays President, Chief Executive Officer & Director
Kevin R. Karas CFO, Secretary, Treasurer & Senior Vice President
John N. Nunnelly Lead Independent Director
JoAnn M. Martin Independent Director
Donald M. Berwick Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NATIONAL RESEARCH CORPORATION-25.40%1 243
CINTAS CORPORATION33.67%37 633
TELEPERFORMANCE24.79%19 359
UNITED RENTALS42.08%17 093
EDENRED3.30%14 223
RENTOKIL INITIAL PLC10.20%12 435